Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice

British Journal of Haematology

Volumn 108, Issue 3, 2000, Pages 641-652

  Burger, Jan A ^a,b   Baird, Stephen M ^b   Powell, Henry C ^b   Sharma, Sanjai ^b,c   Eling, David J ^a   Kipps, Thomas J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; Antigen presenting cells; Differentiation; GM CSF; Peritoneal cells

Indexed keywords

CD11 ANTIGEN; CD3 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HELA CELLS; HEMATOPOIESIS, EXTRAMEDULLARY; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; LEUKOCYTES; LIVER; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; MUSCLE, SKELETAL; ORGAN SIZE; SPLEEN; STEM CELLS;

EID: 0034118225     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01863.x     Document Type: Article

References (41)

1. Armitage, J.O. (1998) Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 92, 4491-4508.
2. Berns, A.J., Clift, S., Cohen, L.K., Donehower, R.C., Dranoff, G., Hauda, K.M., Jaffee, E.M., Lazenby, A.J., Levitsky, H.I., Marshall, F.F., Mulligan, R.C., Nelson, W.G., Owens, A.H., Padoll, D.M., Parry, G., Partin, A.H., Piantadosi, S., Simons, J.W. & Zabora, J.R. (1995) Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Human Gene Therapy, 6, 347-368.
3. Bollag, G., Clapp. D.W., Shih, S., Adler, F., Zhang, Y.Y., Thompson, P., Lange, B.J., Freedman, M.H., McCormick, F., Jacks, T. & Shannon, K. (1996) Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nature Genetics, 12, 144-148.
4. Cantwell, M.J., Sharma, S., Friedmann, T. & Kipps, T.J. (1996) Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood, 88, 4676-4683.
5. Caux, C., Dezutter-Dambuyant, C., Schmitt, D. & Banchereau, J. (1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature, 360, 258-261.
6. Chapuis. F., Rosenzwajg, M., Yagello, M., Ekman, M., Biberfeld, P & Gluckman, J.C. (1997) Differentiation of human dendritic cells from monocytes in vitro. European Journal of Immunology, 27, 431-441.
7. Chiang, C.S., Powell, H.C., Gold, L.H., Samimi, A. & Campbell, I.L. (1996) Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. Journal of Clinical Investigations, 97, 1512-1524.
8. Chiodoni, C., Paglia, P., Stoppacciaro, A., Rodolfo, M., Parenza, M. & Colombo, M.P. (1999) Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. Journal of Experimental Medicine, 190, 125-133.
9. Chu, R.S., Askew, D., Noss, E.H., Tobian, A., Krieg, A.M. & Harding, C.V. (1999) CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. Journal of Immunology, 163, 1188-1194.
10. Dai, Y., Schwarz, E.M., Gu, D., Zhang, W.W., Sarvetnick, N. & Verma, I.M. (1995) Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proceedings of the National Academy of Sciences of the United States of America, 92, 1401-1405.
11. Diaz, R.M., Todryk, S., Chong, H., Hart, I.R., Sikora, K., Dorudi, S. & Vile, R.G. (1998) Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer. Gene Therapy, 5, 869-879.
12. Disis, M.L., Bernhard, H., Shiota, P.M., Hand, S.L., Gralow, J.R., Huseby, E.S., Gillis, S. & Cheever, M.A. (1996) Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood, 88, 202-210.
13. Dow, S.W., Elmslie, R.E., Willson, A.P., Roche, L., Gorman, C. & Potter, T.A. (1998) In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. Journal of Clinical Investigations, 101, 2406-2414.
14. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. & Mulligan, R.C. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proceedings of the National Academy of Sciences of the United States of America, 90, 3539-3543.
15. Dunussi-Joannopoulos, K., Dranoff, G., Weinstein, HJ., Ferrara, J.L., Bierer, B.E. & Croop, T.M. (1998) Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines. Blood, 91, 222-230.
16. Ellem, K.A., O'Rourke, M.G., Johnson, G.R., Parry, G., Misko, I.S., Schmidt, C.W., Parsons, P.G., Burrows, S.R., Cross, S., Fell, A., Li, C.L., Bell, J.R., Dubois, P.J., Moss, D.J., Good, M.F., Kelso, A., Cohen, L.K., Dranoff, G. & Mulligan, R.C. (1997) A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunology and Immunotherapy, 44, 10-20.
17. Erbacher, P., Bousser, M.T., Raimond, J., Monsigny, M., Midoux, P. & Roche, A.C. (1996) Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Human Gene Therapy, 7, 721-729.
18. Geissmann, F., Revy, P., Regnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O. & Durandy, A. (1999) TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. Journal of Immunology, 162, 4567-4575.
19. Huang, A.Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D. & Levitsky, H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science, 264, 961-965.
20. Hume, D.A., Robinson, A.P., MacPherson, G.G. & Gordon, S. (1983) The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. Journal of Experimental Medicine, 158, 1522-1536.
21. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. & Steinman, R.M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. Journal of Experimental Medicine, 176, 1693-1702.
22. Iversen, P.O., Lewis, I.D., Turczynowicz, S., Hasle, H., Niemeyer, C., Schmiegelow, K., Bastiras, S., Biondi, A., Hughes, T.P. & Lopez, A.F. (1997) Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice. Blood, 90, 4910-4917.
23. Johnson, G.R., Gonda, T.J., Metcalf, D., Hariharan, I.K. & Cory, S. (1989) A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO Journal, 8, 441-448.
24. Larsen, C.P., Ritchie, S.C., Hendrix, R., Linsley, P.S., Hathcock, K.S., Kodes, R.J., Lowry, R.P. & Pearson, T.C. (1994) Regulation of immunostimulatory function and costimulalory molecule (B7-1 and B7-2) expression on murine dendritic cells. Journal of Immunology, 152, 5208-5219.
25. Lee, C.T., Wu, S., Ciernik, I.F., Chen, H., Nadaf-Rahrov, S., Gabrilovich, D. & Carbone, D.P. (1997) Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor. Human Gene Therapy, 8, 187-193.
26. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E.R., Lyman, S.D., Shortman, K. & McKenna, H.J. (1996) Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. Journal of Experimental Medicine, 184, 1953-1962.
27. McNeel, D.G., Schiffman, K. & Disis, M.L. (1999) Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 93, 2653-2659.
28. Metcalf, D., Shortman, K., Vremec, D., Mifsud, S. & Di Rago, L. (1996) Effects of excess GM-CSF levels on hematopoiesis and leukemia development in GM-CSF/max 41 double transgenic mice Leukemia, 10, 713-719.
29. Miyatake, S., Otsuka, T., Yokota, T., Lee, F. & Arai, K. (1985) Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes EMBO Journal, 4, 2561-2568.
30. Nagai, E., Ogawa, T., Kielian, T., Ikubo, A. & Suzuki, T. (1998) Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice. Cancer Immunology and Immunotherapy, 47, 72-80.
31. Okada, E., Sasaki, S., Ishii, N., Aoki, I., Yasuda, T., Nishioka, K., Fukushima, J., Miyazaki, J., Wahren, B. & Okuda, K. (1997) Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. Journal of Immunology, 159, 3638-3647.
32. Peters, J.H., Gieseler, R., Thiele, B. & Steinbach, F. (1996) Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunology Today, 17, 273-278.
33. Rezzani, R., Rodella, L., Zauli, G., Caimi, L. & Vitale, M. (1999) Mouse peritoneal cells as a reservoir of late dendritic cell progenitors. British Journal of Haematology, 104, 111-118.
34. Sallusto, F. & Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulatecl by tumor necrosis factor alpha. Journal of Experimental Medicine, 179, 1109-1118.
35. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products [see comments]. Journal of Experimental Medicine, 182, 389-400.
36. Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J.C., Hodi, F.S., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K.K., Cosimi, A.B., Duda, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Dranoff, G., et al. (1998) Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proceedings of the National Academy of Sciences of the United States of America, 95, 13141-13146.
37. Stall, A.M. & Wells, S.M. (1996) FACS analysis of murine B-cell populations. Weir's Handbook of Experimental Immunology, Vol. 2 (ed. by L.A. Herzenberg, D.M. Weir, L.A. Herzenberg & C. Blackwell), pp. 63.1-63.17. Blackwell Science, Cambridge, MA.
38. Takahashi, K., Asagoe, K., Zaishun, J., Yanai, H., Yoshino, T., Hayashi, K. & Akagi, T. (1998) Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. American Journal of Pathology, 153, 745-755.
39. Tripathy, S.K., Black, H.B., Goldwasser, E. & Leiden, J.M. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adeno-virus vectors. Nature Medicine, 2, 545-550.
40. Verma, I.M. & Somia, N. (1997) Gene therapy - promises, problems and prospects [news]. Nature, 389, 239-242.
41. Zhang, Y., Zhang, Y.Y., Ogata, M., Chen, P., Harada, A., Hashimoto, S. & Matsushima, K. (1999) Transforming growth factor-beta 1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway. Blood, 93, 1208-1220.